Pls give me critical drug values of Inj MgSO4, Inj Tramadol, Inj Methergine, Inj Oxytocin, Inj Labetalol, Inj Carboprost,
I'll look up the critical drug values for all 6 injectable medications from the medical library simultaneously.
Searching sources...
Reading File
Now I'll run parallel searches for all 6 drugs simultaneously:
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Let me get more specific clinical data from the key textbook sections found:
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I now have comprehensive data from authoritative textbooks. Let me compile the full critical drug values table:
Critical Drug Values - Injectable Medications
Sources: Roberts & Hedges' Clinical Procedures in Emergency Medicine, Miller's Anesthesia 10e, Creasy & Resnik's Maternal-Fetal Medicine, Barash Clinical Anesthesia 9e
1. Inj Magnesium Sulfate (MgSO4)
| Parameter | Value |
|---|---|
| Concentration available | 50% solution (500 mg/mL) |
| Loading dose (eclampsia/pre-eclampsia) | 4-6 g IV over 20-30 minutes |
| Maintenance dose | 1-3 g/hr IV infusion |
| Tocolytic dose | 4-6 g IV over 20 min, then 1-3 g/hr |
| Arrhythmia (VF) | 1-2 g IV over 1-2 minutes |
| IM route | 5 g deep IM (each buttock) - discouraged (painful) |
| Antidote | Calcium gluconate 10% - 10 mL IV over 3 min |
| Route | IV (preferred), IM |
Toxicity monitoring (serum Mg levels):
| Serum Level | Effect |
|---|---|
| 4-7 mEq/L | Therapeutic range |
| >4 mEq/L | Loss of patellar reflex (first sign of toxicity) |
| >10 mEq/L | Respiratory muscle impairment |
| >12 mEq/L | Respiratory arrest |
| >15 mEq/L | Cardiac arrest |
Clinical monitoring: Patellar reflex (loss = toxicity), urine output (>25 mL/hr required), respiratory rate (>12/min required). Contraindicated in renal failure.
2. Inj Tramadol
| Parameter | Value |
|---|---|
| Usual dose | 50-100 mg per dose |
| Route | IV / IM / SC |
| Frequency | Every 4-6 hours |
| Maximum daily dose | 400-500 mg/day |
| IV administration | Slow IV over 15-20 min (rapid bolus causes nausea/seizures) |
| Class | Centrally acting opioid agonist + NE/serotonin reuptake inhibitor |
NNT by dose (for adequate analgesia):
- 50 mg: NNT = 8.5
- 75 mg: NNT = 5.3
- 100 mg: NNT = 4.8
- 150 mg: NNT = 2.9
Key cautions: Serotonin syndrome risk (especially with SSRIs/SNRIs/MAOIs); lowers seizure threshold; reduce dose in renal/hepatic impairment; avoid in patients on MAOIs.
3. Inj Methylergometrine (Methergine)
| Parameter | Value |
|---|---|
| Standard dose | 0.2 mg IM |
| Frequency | Every 2-4 hours |
| Max doses | 5 doses (total 1 mg) |
| Onset (IM) | 2-5 minutes |
| Duration | Several hours of sustained contractions |
| IV route | Only in life-threatening hemorrhage - very slowly (risk of severe HTN) |
| Oral (maintenance) | 0.2 mg TDS x 7 days |
Indications: Second-line PPH (after oxytocin), uterine atony, active management of third stage of labor.
Absolute contraindications:
- Hypertensive disorders (pre-eclampsia, PIH) - causes severe hypertension
- Pre-delivery / induction of labor
- Coronary artery disease
- Peripheral vascular disease
4. Inj Oxytocin
| Parameter | Value |
|---|---|
| PPH treatment dose (IV infusion) | 20-40 units in 1 L crystalloid at 200-500 mL/hr, titrate |
| If no IV access | 10 units IM or intrauterine |
| Labor augmentation/induction | Start at 0.5-2 mU/min, increase by 1-2 mU/min every 30 min; max 20-40 mU/min |
| Active 3rd stage management | 10 units IM (WHO recommendation) |
| Concentration | 10 units/mL (standard ampoule) |
Critical warnings:
- NEVER give as IV bolus - causes severe acute hypotension, cardiac arrest
- Has antidiuretic effect at high doses - risk of water intoxication/hyponatremia
- Tachyphylaxis occurs with prolonged infusion
- Use lowest effective dose; continuous CTG monitoring required during labor augmentation
5. Inj Labetalol
| Parameter | Value |
|---|---|
| Bolus dose (acute severe HTN in pregnancy) | 20 mg IV bolus over 2 min |
| Repeat boluses | 40 mg → 80 mg every 10-15 min |
| Maximum total bolus dose | 300 mg |
| Continuous infusion | 0.5-2 mg/min IV (up to 300 mg total) |
| Onset (IV) | 5 minutes |
| Duration (IV) | 45 min - 6 hours |
| Target BP in pregnancy | <160/110 mmHg (acute); <150/100 mmHg (sustained) |
Contraindications:
- Asthma / severe bronchospasm
- Bradycardia (HR <60)
- 2nd/3rd degree heart block
- Cardiogenic shock / decompensated heart failure
- Prinzmetal angina
Note: Labetalol is alpha + beta blocker (alpha:beta ratio = 1:7 IV). Safe in pregnancy; does not significantly reduce uteroplacental blood flow.
6. Inj Carboprost (15-methyl PGF2α / Hemabate)
| Parameter | Value |
|---|---|
| Standard dose | 250 mcg (0.25 mg) IM |
| Repeat interval | Every 15-90 minutes |
| Maximum total dose | 2 mg (8 doses) |
| Route | IM (intramyometrial in selected cases) |
| Onset | Within minutes |
| Indication | Refractory PPH due to uterine atony (after oxytocin fails) |
Concurrent medications recommended: Antiemetics (ondansetron/metoclopramide) + antidiarrheal agents to manage side effects.
Contraindications:
- Asthma (causes severe bronchospasm - absolute contraindication)
- Active cardiac, renal, hepatic, or pulmonary disease
- Hypersensitivity to prostaglandins
Side effects: Nausea, vomiting, diarrhea, bronchospasm, flushing, pyrexia, transient hypertension.
Quick Reference Summary
| Drug | Route | Key Dose | Max Dose | Critical Alert |
|---|---|---|---|---|
| MgSO4 | IV | Load 4-6 g, then 1-3 g/hr | Monitor levels | Antidote: Ca gluconate; patellar reflex loss = toxicity |
| Tramadol | IV/IM | 50-100 mg q4-6h | 400 mg/day | Serotonin syndrome risk |
| Methergine | IM | 0.2 mg q2-4h | 1 mg total | Contraindicated in HTN/pre-eclampsia |
| Oxytocin | IV infusion | 20-40 U in 1L at 200-500 mL/hr | Titrate | NEVER IV bolus |
| Labetalol | IV bolus | 20 mg → 40 mg → 80 mg | 300 mg | Contraindicated in asthma |
| Carboprost | IM | 250 mcg q15-90 min | 2 mg (8 doses) | Contraindicated in asthma |
This is a shared conversation. Sign in to Orris to start your own chat.